Summary
The kinetics of single 30-mg oral doses of oxazepam were determined in 22 male and nine female volunteers aged 20–86 years. Oxazepam plasma concentrations were measured in multiple plasma samples drawn during 36 h after each dose. Mean kinetic variables in males and females, respectively, were: elimination half-life, 7.5 and 8.5 h; volume of distribution, 0.96 and 1.17 l/kg; clearance, 1.48 and 1.70 ml/min/kg. Sex differences were not significant, nor were any of the kinetic variables significantly related to age. However, oxazepam clerance increased significantly with heavier cigarette smoking (r=0.48,p<0.01). Mean clearance in smokers (1.98 ml/min/kg) was significantly higher than in non-smokers (1.23 ml/min/kg,p<0.01). Thus, smoking is a more important determinant of oxazepam clearance than age or sex.
Zusammenfassung
Bei 31 Versuchspersonen (22 männliche, neun weibliche) wurde die Kinetik von Oxazepam nach einer einmaligen oralen Gabe von 30 mg gaschromatographisch bestimmt. Das mittlere Alter der beiden Versuchsgruppen lag bei 51 bzw. 44 Jahren (Bereich: 22–86 Jahre). Die kinetischen Variablen für die männlichen und weiblichen Versuchsgruppen lauten (in Klammern der Bereich): Eliminationshalbwertzeit: 7,5 h (3,2 h–19,8 h) bzw. 8,5 h (3,4 h–12,4 h); Verteilungsvolumen: 0,96 (0,44–2,91) bzw. 1,17 (0.60–-3,12) l/kg Körpergewicht; Clearance 1,48 (0,62–3,00) bzw. 1,70 (0,56–3,73) ml/min/kg; Zeitpunkt der maximalen Plasmakonzentration: 2,2 h (0,75 h–6,0 h) bzw. 1,7 h (0,75 h–3,0 h) nach Tabletteneinnahme; maximale Plasmakonzentration 646 (242–1195) bzw. 653 (447–854) ng/ml.
Geschlechtsbedingte Unterschiede in der Kinetik ließen sich im Gegensatz zu anderen Benzodiazepinen, wie z.B. Diazepam oder Desmethyldiazepam, nicht nachweisen. Ebenso bestanden keine signifikanten Korrelationen zwischen den kinetischen Variablen und dem Alter der Probanden. Auch hierin unterscheidet sich Oxazepam von den meisten anderen Benzodiazepinen. Dagegen ließ sich eine signifikante Beziehung zwischen der Clearance und dem Zigarettenkonsum der Probanden ableiten: sie war bei den Rauchern mit 1,98 ml/min/kg deutlich höher als bei den Nichtrauchern (1,23 ml/min/kg) (p<0,01).
Im Gegensatz zu anderen Benzodiazepinen beeinflussen die Rauchergewohnheiten die Kinetik des Oxazepam mehr als die alters- oder geschlechtsgebundenen Faktoren.
Similar content being viewed by others
References
Allen MD, Greenblatt DJ, Harmatz JS, Shader RI (1980) Desmethyldiazepam kinetics in the elderly after oral prazepam. Clin Pharmacol Therap 28:196–202
Boston Collaborative Drug Surveillance Program (1973) Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. N Engl J Med 288:277–280
Castleden CM, George CF, Marcer D, Hallet C (1977) Increased sensitivity to nitrazepam in old age. Br Med J 1:10–12
Chinnery R, Sundwell A (eds) (1978) Pharmacodynamic, pharmacokinetic, and clinical aspects on oxazepam and related benzodiazepines. Acta Psychiat Scand (Suppl) 274:9–128
Greenblatt DJ, Allen MD (1978) Toxicity of nitrazepam in the elderly:a report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol 5:407–413
Greenblatt DJ, Allen MD, Harmatz JS, Shader RI (1980) Diazepam disposition determinants. Clin Pharmacol Therap 27:301–312
Greenblatt DJ, Allen MD, Locniskar A, Harmatz JS, Shader RI (1979) Lorazepam kinetics in the elderly. Clin Pharmacol Therap 26:103–113
Greenblatt DJ, Allen MD, Shader RI (1977) Toxicity of high-dose flurazepam in the elderly. Clin Pharmacol Therap 21:355–361
Greenblatt DJ, Divoll M, Harmatz JS, Shader RI (1980) Oxazepam kinetics: effects of age and sex. J Pharmacol Exp Therap 215:86–91
Greenblatt DJ, Franke K, Shader RI (1978) Analysis of lorazepam and its glucuronide metabolite by electron-capture gasliquid chromatography: use in pharmacokinetic studies of lorazepam. J Chromatogr 146:311–320
Greenblatt DJ, Harmatz JS, Stanski DR, Shader RI, Franke K, Koch-Weser J (1977) Factors influencing blood concentrations of chlordiazepoxide: a use of multiple regression analysis. Psychopharmacology 54:277–282
Greenblatt DJ, Koch-Weser J (1975) Clinical pharmacokinetics. New Engl J Med 293:702–705, 964–970
Greenblatt DJ, Shader RI, Franke K, MacLaughlin DS, Harmatz JS, Allen MD, Werner A, Woo E (1979) Pharmacokinetics and biovailability of inravenous, intramuscular, and oral lorazepam in humans. J Pharmaceut Sci 68:57–63
Johnson RF, Schenker S, Roberts RK, Desmond PV, Wilkinson GR (1979) Plasma binding of benzodiazepines in humans. J Pharmaceut Sci 68:1320–1322
Jusko WJ (1979) Influence of cigarette smoking on drug metabolism in man. Drug Metab Rev 9:221–236
Kanto J, Maenpaa M, Mantyla R, Sellman R, Valovirta E (1979) Effect of age on the pharmacokinetics of diazepam given in conjunction with spinal anesthesia. Anesthesiology 51:154–159
Kraus JW, Desmond PV, Marshall JP, Johnson RF, Schenker S, Wilkinson GR (1978) Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Therap 24:411–419
Reidenberg MM, Levy M, Warner H, Coutinho CB, Schwartz MA, Yu G, Cheripko J (1978) Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Therap 23:371–374
Roberts RK, Wilkinson GR, Branch RA, Schenker S (1978) Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium): Gastroenterology 75:479–485
Shader RI, Greenblatt DJ, Harmatz JS, Franke K, Koch-Weser J (1977) Absorption and disposition of chlordiazepoxide in young and elderly male volunteers. J Clin Pharmacol 17:709–718
Shull HJ, Wilkinson GR, Johnson R, Schenker S (1976) Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med 84:420–425
Vestal RE (1978) Drug use in the elderly: a review of problems and special considerations. Drugs 16:358–382
Author information
Authors and Affiliations
Additional information
Supported in part by Grant Oc 10/4 from the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Federal Republic of Germany; and Grant MH-34223 from the United States Public Health Service
Rights and permissions
About this article
Cite this article
Ochs, H.R., Greenblatt, D.J. & Otten, H. Disposition of oxazepam in relation to age, sex, and cigarette smoking. Klin Wochenschr 59, 899–903 (1981). https://doi.org/10.1007/BF01721923
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01721923